GE HealthCare Technologies $GEHC (+0,13 %) recently held an analyst meeting at which the company updated its long-term targets and forecasts. Despite a positive outlook, the stock fell 3.4% to USD 82, while the S&P 500 and Dow Jones rose. For 2024, GE HealthCare expects earnings per share between USD 4.25 and USD 4.35, which is in line with expectations. In the long term, organic sales growth of 4-6% and a profit margin of over 20% are targeted. However, uncertainties in the Chinese market could impact share performance.